Dengue: cardiac manifestations and implications in antithrombotic treatment.
Pesaro
Antonio Eduardo
AE
Hospital Israelita Albert Einstein, São Paulo, SP, Brasil. eduardopesaro@hotmail.com
D'Amico
Elbio
E
Aranha
Luis Fernando C
LF
D000925:Anticoagulants / Q000008:administration & dosage*; D003715:Dengue / Q000150:complications* / Q000175:diagnosis; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006331:Heart Diseases / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D012307:Risk Factors; D015912:Thrombolytic Therapy; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control*; D013997:Time Factors
D000925:Anticoagulants; D005343:Fibrinolytic Agents